Pharmaceutical

Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion

Rona Therapeutics has secured $35m in its Series A+ financing round to advance its metabolic siRNA pipeline in clinical settings.

Jul 20, 2024 - 04:00
Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion
Rona Therapeutics has secured $35m in its Series A+ financing round to advance its metabolic siRNA pipeline in clinical settings.
Read the original article

Tags:

Previous Article

Seventh patient ‘cured’ of HIV among highlights at AIDS 2024

Next Article

Meitheal gains rights to CONTEPO from Nabriva in North America

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Living kidney donors rely on a promise to protect our future health. We’re scared it will go away

Opinion: Living kidney donors rely on a promise to prot...

Mar 22, 2023

Panama updates their medicine regulatory system

Panama updates their medicine regulatory system

Mar 1, 2024

STAT+: Under-the-skin injection of Eisai’s Leqembi is as effective as IV infusion, new Alzheimer’s data show

STAT+: Under-the-skin injection of Eisai’s Leqembi is a...

Oct 26, 2023